Experienced Drug Development Consultant Bina Keshavan, PhD

Dr. Bina Keshavan is the owner and principal consultant of Adagia Pharma Consulting based in New Jersey. Her expertise includes providing leadership in drug development for early and late stage programs across multiple modalities such cell and gene therapies, small molecules and biologics. Her drug development and program management experience ranges from rare diseases, such as Angelman syndrome, to common health conditions, such as obesity.

In addition to her consulting work with Adagia, Dr. Bina Keshavan has published numerous articles and papers. She has written about Angelman syndrome for the European Journal of Paediatric Neurology and the Journal of Comparative Neurology, among other publications.

Dr. Keshavan studied neuroscience at Dalhousie University in Canada as a Killam Scholar. Apart from her work in drug development, she is an avid traveler. She has visited numerous international destinations, including Mexico, Costa Rica, over 15 European countries, Tanzania, Australia, Israel, Turkey, Japan and Nepal. She also enjoys puzzles, from jigsaw puzzles to crosswords.